COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn BHBH FPVFPV FLVFLV PVP-IPI REGNR2 LY-CoVLY RMDRMD
LY-CoV news
10/26 News
Lilly (News)
Lilly Statement Regarding NIH’s ACTIV-3 Clinical Trial
Source   PDF   Share   Tweet
ACTIV-3 intermin analysis shows LY-CoV555 is unlikely to help hospitalized patients. ACTIV-2, BLAZE-1 and BLAZE-2 trials remain ongoing.

Lilly et al., 10/26/2020, preprint, 1 author.
Details of all 5 studies
Please send us corrections, updates, or comments.
Submit